MedTrace Logo

The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels

NCT01106703 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2010-07-27

No results posted yet for this study

Summary

The aim of this study was to evaluate the efficacy of PG102 at lowering levels of total IgE in asymptomatic subjects with atopy.

Conditions

  • Asymptomatic Subjects With Atopy and Elevated Serum IgE

Interventions

DIETARY_SUPPLEMENT

PG102, a water soluble extract from Actinidia arguta

PG102 two tables(Actinidia arguta extract:Microcrystalline cellulose(1:1)mixed powder 1120mg) twice a day for 8weeks

OTHER

placebo

placebo two tables(equivalent dose of Microcrystalline cellulose) twice a day for 8weeks

Sponsors & Collaborators

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kyung-Up Min, M.D., Ph.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2008-03-31
Completion
2008-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01106703 on ClinicalTrials.gov